Ekso Bionics Holdings, Inc., a robotic exoskeleton company, announced today that their robotic technology expertise will be featured on two separate panels at the International Consumer Electronics Show (CES).
Nate Harding, chief executive officer and co-founder will be speaking on The Future of Robotics, presented by Engadget today, January 6th, 1:00-2:00 pm at the Las Vegas Convention Center, North Hall, Room N257.
Russ Angold, president of Ekso Labs™ and co-founder will be speaking on Wearable Robotics: From Healing to Enhancement on January 8 from 10:15-11:15 AM at the Venetian, Level 1, Casanova 602.
Multiple robotic exoskeleton companies are gaining traction with medical applications of robotic exoskeleton technologies for ambulation, such as gait-training devices in rehabilitation institutions. FDA recently implemented a new classification regulation specifically for Powered Exoskeletons, which are now considered class II devices subject to the agency's 510(k) premarket notification requirements. In discussions with FDA following implementation of this new regulation, Ekso Bionics committed to filing a 510(k) notice for the Ekso device under the new classification regulation by the end of 2014. This 510(k) notice was filed in late December 2014 and the company has been allowed to continue to market the device while this submission is under review.